Nevro Announces SENZA-PDN Clinical Data Presentations at the American Diabetes Association 82nd Scientific Sessions
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
United States Redwood City Erika Petersen George Grunberger Julie Dewey Trinity Partners Market Research
Source: prnewswire.com